Mersana Therapeutics buy Guggenheim
Start price
14.06.23
/
50%
€5.54
Target price
14.06.24
-
Performance (%)
-66.10%
End price
15.06.24
€1.88
Summary
This prediction ended on 15.06.24 with a price of €1.88. The BUY prediction by Guggenheim for Mersana Therapeutics performed very badly with a performance of -66.10%. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Mersana Therapeutics | 3.553% | 3.553% | 65.057% |
iShares Core DAX® | -0.598% | 0.645% | 10.813% |
iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% |
iShares Nikkei 225® | -0.796% | -0.582% | 8.390% |
iShares S&P 500 | -1.164% | -0.857% | 23.003% |
Comments by Guggenheim for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten